Efficacy and safety of initial treatment (combination immunotherapy or chemotherapy + ICI) in advanced non-small cell lung cancer patients (TPS 1-49%): A multicenter retrospective observational study (TOPGAN2023-01)
Not Applicable
Recruiting
- Conditions
- non small cell carcinoma
- Registration Number
- JPRN-UMIN000052228
- Lead Sponsor
- department of respiratory medicine hirosaki university graduate school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1 Positive for genetic mutations (EGFR common mutation/ALK), LCNEC 2 The attending physician has deemed the patient ineligible for registration in this study. 3 Has an active concurrent cancer that affects prognosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method